New Trial Data: ST-920 Gene Therapy Effective, Well-tolerated in Fabry

A Special Place for the Fabry Disease Community

One evening in mid-2008, my wife, Angela, and I were watching television at home and saw an advertisement about Victory Junction, a camp in Randleman, North Carolina. The camp has a race car theme in honor of the late NASCAR driver Adam Petty and serves children with…

No Extra Fabry-related Risks With COVID-19, Small Study Concludes

The risk of severe COVID-19 in people with Fabry disease appears to be driven by immune system function rather than by the genetic disorder itself — “similar to the general population” — a small study concluded. “Immunosuppression therapy in kidney transplant recipients represented the highest risk in this [patient]…

European Teens Report High Fabry Burden, Not Fully Lessened by ERT

The Fabry disease burden is variable but significant among adolescents and caregivers, affecting their quality of life and mental health, according to results of online surveys in three European countries. In addition, standard enzyme replacement therapy (ERT) was reported to reduce the disease’s burden, but not fully. These findings highlight…

Patients Wanted to Test Device for Detecting Cardiac Problems in Fabry

A clinical study in the U.K. is recruiting adults with Fabry disease (FD) to determine whether implantable loop recorders (ILRs) — a device for continuous heart monitoring — can improve arrhythmia detection and identify risk predictors for cardiac problems. Participants’ heart rhythms will be tracked, using the surgically implanted…